profit from every $100 of sales.
$0$100
Oscar Health
$31.05-2.79% today
+122.6% in 1 year
1-year low $10.851-year high $35.19
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Oscar Health sold, what it kept, and what it did with the cash.
Sales went from $4.13 billion in 2022 to $11.7 billion in 2025, with -$443 million of profit last year.
SalesProfit
Oscar Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Oscar Health | No profit yet | ||
 UnitedHealth | 30.3× · Expensive | ||
 CVS Health | 64.7× · Very expensive | ||
 Elevance Health | 16.4× · Fair price | ||
 The Cigna Group | 13.1× · Cheap |
AI analysis
An AI analyst reads Oscar Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 463 | 1,839 | 4,126 | 5,863 | 9,178 | 11,701 | |
| – | – | – | – | – | – | |
| -402 | -544 | -590 | -236 | 57 | -396 | |
| -391 | -551 | -572 | -212 | 89 | -391 | |
| -407 | -573 | -606 | -271 | 25 | -443 | |
| -14.16 | -3.20 | -2.85 | -1.22 | 0.10 | -1.69 | |
| – | – | – | – | – | – | |
| -86.9% | -29.6% | -14.3% | -4.0% | 0.6% | -3.4% | |
| -87.9% | -31.1% | -14.7% | -4.6% | 0.3% | -3.8% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 2,272 | 3,322 | 4,527 | 3,601 | 4,840 | 6,325 |
| Cash | 826 | 1,104 | 1,559 | 1,870 | 1,527 | 2,774 |
| Total debt | 142 | 0 | 298 | 299 | 300 | 430 |
| Total liabilities | 1,823 | 1,929 | 3,634 | 2,795 | 3,824 | 5,345 |
| -1,296 | 1,387 | 890 | 804 | 1,014 | 978 | |
| 29 | 179 | 212 | 222 | 266 | 262 | |
| – | -32.2% | -39.1% | -17.4% | 3.4% | -23.6% | |
| 31.4% | -41.3% | -68.1% | -33.7% | 2.5% | -45.3% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 223 | -182 | 380 | -272 | 978 | 1,095 | |
| 14 | 26 | 29 | 26 | 28 | 36 | |
| 209 | -208 | 351 | -298 | 950 | 1,058 | |
| Dividends paid | – | – | – | – | – | – |
| 0 | 0 | – | – | – | – | |
| 36 | 86 | 112 | 160 | 110 | 88 |
Valuation
- –
- 51.6×
- –
- 10.2×
- 0.8×
- 9.1×
- –
- 11.0%
- -4.6%
- 0.0%
Profitability
- 17.4%
- -3.4%
- -3.8%
- 0.1%
- -24.1%
- -19.6%
- -3.3%
- -0.4%
- 0.5%
- –
Growth
- +90.8%
- –
- +11.4%
- –
- +7.3%
Financial health
- -6.0×
- 0.44
- 4.6%
- -23.8×
- 1.09
- 1.09
- 1.43
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 14%of 964
Bottom 16%of 898
Top 6%of 911
Top 7%of 991
What analysts expect
- Average price target
- $16.75
- Range
- $15.00 – $18.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 2.07 | 1.21 | +71.1% |
| Feb 10, 2026 | -1.24 | -0.92 | −34.6% |
| Nov 6, 2025 | -0.53 | -0.55 | +3.6% |
| Aug 6, 2025 | -0.89 | -0.90 | +1.1% |
| May 7, 2025 | 0.92 | 0.83 | +10.8% |
| Feb 4, 2025 | -0.62 | -0.55 | −12.7% |
| Nov 7, 2024 | -0.22 | -0.20 | −10.0% |
| Aug 7, 2024 | 0.20 | 0.16 | +25.0% |
News
Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?Yahoo Finance · Sep 1, 2026The newest story we have is from Sep 1, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
33No pass
Benjamin Graham
22No pass
Philip Fisher
32No pass
Peter Lynch
69Pass
Joel Greenblatt
0No pass
Charlie Munger
17No pass
Terry Smith
18No pass
Questions about Oscar Health
Is Oscar Health a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Oscar Health AI analysis
What does Oscar Health do?
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It is in Healthcare Plans, based in New York, NY, United States, with 2,305 employees.
Does Oscar Health pay a dividend?
No. Oscar Health does not pay a dividend at the moment.
Is Oscar Health stock halal?
No. Oscar Health does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Oscar Health stock done over the past year?
Up 122.6% over the past twelve months, to $31.05. It traded between $10.85 and $35.19 and is 11.8% below its high.
Who are Oscar Health's competitors?
The largest listed companies in the same industry are UnitedHealth, CVS Health, Elevance Health and The Cigna Group. The peers table on this page compares their profit, growth and price with Oscar Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.